The Second Affiliated Hospital of Zhejiang University School of Medicine — Hangzhou, Zhejiang

Public research footprint of The Second Affiliated Hospital of Zhejiang University School of Medicine, compiled from the ClinicalTrials.gov public registry.

321

Registered studies

155

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

HR Low-Positive/HER2-Negative Breast Neoplasms · Healthy Allogeneic Hematopoietic Stem Cell Donor · Primary Sjögren's Syndrome · Triple Negative Breast Neoplasms

Recently updated registry entries

NCT03888105 — A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients… (Active Not Recruiting)
NCT06806293 — Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult… (Active Not Recruiting)
NCT04588922 — Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Second Affiliated Hospital of Zhejiang University School of Medicine?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.